Fortis Healthcare Limited

BSE:532843 Stock Report

Market Cap: ₹515.5b

Fortis Healthcare Valuation

Is 532843 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 532843 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 532843 (₹683.2) is trading above our estimate of fair value (₹351.52)

Significantly Below Fair Value: 532843 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 532843?

Key metric: As 532843 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 532843. This is calculated by dividing 532843's market cap by their current earnings.
What is 532843's PE Ratio?
PE Ratio78.6x
Earnings₹6.56b
Market Cap₹515.49b

Price to Earnings Ratio vs Peers

How does 532843's PE Ratio compare to its peers?

The above table shows the PE ratio for 532843 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average71.6x
NH Narayana Hrudayalaya
34x13.6%₹264.9b
MEDANTA Global Health
60.3x20.0%₹294.5b
APOLLOHOSP Apollo Hospitals Enterprise
87.7x30.7%₹1.0t
543220 Max Healthcare Institute
104.6x30.8%₹1.1t
532843 Fortis Healthcare
78.6x26.8%₹515.5b

Price-To-Earnings vs Peers: 532843 is expensive based on its Price-To-Earnings Ratio (78.6x) compared to the peer average (71.6x).


Price to Earnings Ratio vs Industry

How does 532843's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.4xn/aUS$13.33m
542918 Gian Life Care
5xn/aUS$2.27m
No more companies available in this PE range
532843 78.6xIndustry Avg. 42.4xNo. of Companies8PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 532843 is expensive based on its Price-To-Earnings Ratio (78.6x) compared to the Indian Healthcare industry average (43.4x).


Price to Earnings Ratio vs Fair Ratio

What is 532843's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

532843 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio78.6x
Fair PE Ratio73.1x

Price-To-Earnings vs Fair Ratio: 532843 is expensive based on its Price-To-Earnings Ratio (78.6x) compared to the estimated Fair Price-To-Earnings Ratio (73.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 532843 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹683.20
₹685.36
+0.3%
8.0%₹728.00₹550.00n/a14
Dec ’25₹660.05
₹685.36
+3.8%
8.0%₹728.00₹550.00n/a14
Nov ’25₹635.20
₹559.73
-11.9%
9.0%₹680.00₹490.00n/a15
Oct ’25₹615.50
₹555.53
-9.7%
8.1%₹680.00₹490.00n/a15
Sep ’25₹551.70
₹543.20
-1.5%
6.1%₹595.00₹490.00n/a15
Aug ’25₹504.95
₹525.86
+4.1%
5.7%₹595.00₹482.00n/a14
Jul ’25₹471.60
₹506.07
+7.3%
8.0%₹558.00₹390.00n/a14
Jun ’25₹475.95
₹506.07
+6.3%
8.0%₹558.00₹390.00n/a14
May ’25₹438.20
₹482.23
+10.0%
6.9%₹515.00₹390.00n/a13
Apr ’25₹428.35
₹482.31
+12.6%
6.9%₹515.00₹390.00n/a13
Mar ’25₹400.30
₹475.71
+18.8%
8.4%₹515.00₹390.00n/a14
Feb ’25₹427.00
₹434.71
+1.8%
9.8%₹495.00₹364.00n/a14
Jan ’25₹439.45
₹416.86
-5.1%
7.4%₹475.00₹364.00n/a14
Dec ’24₹383.20
₹407.14
+6.2%
5.5%₹450.00₹364.00₹660.0514
Nov ’24₹327.20
₹374.67
+14.5%
6.2%₹415.00₹333.00₹635.2012
Oct ’24₹339.95
₹374.67
+10.2%
6.2%₹415.00₹333.00₹615.5012
Sep ’24₹324.85
₹373.00
+14.8%
6.2%₹415.00₹333.00₹551.7012
Aug ’24₹346.05
₹355.30
+2.7%
7.6%₹404.00₹319.00₹504.9510
Jul ’24₹314.80
₹350.30
+11.3%
7.3%₹404.00₹319.00₹471.6010
Jun ’24₹279.10
₹340.00
+21.8%
7.5%₹404.00₹319.00₹475.959
May ’24₹260.50
₹338.63
+30.0%
4.3%₹361.00₹322.00₹438.208
Apr ’24₹259.95
₹342.38
+31.7%
4.0%₹361.00₹325.00₹428.358
Mar ’24₹268.65
₹342.38
+27.4%
4.0%₹361.00₹325.00₹400.308
Feb ’24₹277.95
₹344.25
+23.9%
3.9%₹361.00₹319.00₹427.008
Jan ’24₹286.15
₹343.38
+20.0%
4.0%₹361.00₹319.00₹439.458
Dec ’23₹291.05
₹343.38
+18.0%
4.0%₹361.00₹319.00₹383.208

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:09
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fortis Healthcare Limited is covered by 38 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited